| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/27/2001 | WO2001098343A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 12/27/2001 | WO2001098317A2 Alpha-glycosylceramides for treating bacterial and fungal infections |
| 12/27/2001 | WO2001098307A1 Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098306A1 Compounds for treating impaired fundic relaxation |
| 12/27/2001 | WO2001098303A1 Novel process for the preparation of pyrazolopyrimidinones |
| 12/27/2001 | WO2001098302A1 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
| 12/27/2001 | WO2001098300A1 Medicines for the prevention and treatment of neurodegenerative diseases |
| 12/27/2001 | WO2001098299A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | WO2001098298A1 Indole derivatives useful for the treatment of cns disorders |
| 12/27/2001 | WO2001098297A2 A thiazine oxazolidinone |
| 12/27/2001 | WO2001098295A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098293A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/27/2001 | WO2001098289A1 Novel non-psychotropic cannabinoids |
| 12/27/2001 | WO2001098286A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | WO2001098284A1 Process for the preparation of pyrazolopyrimidinones |
| 12/27/2001 | WO2001098279A2 Bis-arylsulfones |
| 12/27/2001 | WO2001098278A1 Methods and compositions utilizing quinazolinones |
| 12/27/2001 | WO2001098277A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 12/27/2001 | WO2001098275A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 12/27/2001 | WO2001098273A1 Novel compounds |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098267A1 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 12/27/2001 | WO2001098262A1 Amidine derivatives as selective antagonists of nmda receptors |
| 12/27/2001 | WO2001098259A1 7-phenyl-substituted tetracycline compounds |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098253A2 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinicreceptor antagonists |
| 12/27/2001 | WO2001098250A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/27/2001 | WO2001098248A2 Hiv integrase inhibitors |
| 12/27/2001 | WO2001098236A2 7-phenyl-substituted tetracycline compounds |
| 12/27/2001 | WO2001098235A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 12/27/2001 | WO2001098206A1 Delivery vehicle composition and methods for delivering antigens and other drugs |
| 12/27/2001 | WO2001097872A1 Bioadhesive compositions and methods of preparation and use |
| 12/27/2001 | WO2001097861A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | WO2001097857A1 Preparations for oligonucleotide transfer |
| 12/27/2001 | WO2001097851A2 Compositions and methods to improve the oral absorption of antimicrobial agents |
| 12/27/2001 | WO2001097850A2 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 12/27/2001 | WO2001097849A1 Antitumor effect potentiators |
| 12/27/2001 | WO2001097848A2 Vitronectin receptor antagonist pharmaceuticals |
| 12/27/2001 | WO2001097846A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 12/27/2001 | WO2001097838A2 Adjuvants and processes to induce a specific type of immune response |
| 12/27/2001 | WO2001097829A2 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| 12/27/2001 | WO2001097819A1 Influenza virus binding, sialylated oligosaccharide substance and use thereof |
| 12/27/2001 | WO2001097818A1 Fortifying vitamin compositions |
| 12/27/2001 | WO2001097816A1 Use of amp kinase activators for treatment of type 2 diabetes and insulin resistance |
| 12/27/2001 | WO2001097815A2 Use of glucocorticosteroids for producing a medicament to treat oligotrichia |
| 12/27/2001 | WO2001097814A1 Photosensitizers with ligand targeting properties for tumor therapy |
| 12/27/2001 | WO2001097813A2 Highly concentrated stable meloxicam solutions |
| 12/27/2001 | WO2001097812A1 Tetracyclic compounds-containing pharmaceutical preparations |
| 12/27/2001 | WO2001097811A1 Method for the treatment of overactive bladder |
| 12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
| 12/27/2001 | WO2001097809A2 Method of treating cardiovascular disease using rapamycin |
| 12/27/2001 | WO2001097808A1 Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus |
| 12/27/2001 | WO2001097807A1 New use of angiotensin ii antagonists |
| 12/27/2001 | WO2001097806A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 12/27/2001 | WO2001097805A2 Solid valsartan pharmaceutical compositions |
| 12/27/2001 | WO2001097804A1 Medicaments |
| 12/27/2001 | WO2001097803A1 Pharmaceutical preparations comprising racecadotril (acetorphan) |
| 12/27/2001 | WO2001097802A1 Supplement to enhance fertility |
| 12/27/2001 | WO2001097801A2 Dry powder formulation comprising racecadotril |
| 12/27/2001 | WO2001097800A1 Method of stabilizing medicinal compositions containing pravastatin |
| 12/27/2001 | WO2001097799A1 Medium chain fatty acids applicable as antimicrobial agents |
| 12/27/2001 | WO2001097798A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
| 12/27/2001 | WO2001097797A1 Paradoxical pharmacology |
| 12/27/2001 | WO2001097796A1 Clear aqueous anaesthetic composition |
| 12/27/2001 | WO2001097795A2 Systems and methods for treating a mucosal surface |
| 12/27/2001 | WO2001097794A2 Inhibitors of matriptase for the treatment of cancer |
| 12/27/2001 | WO2001097793A2 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| 12/27/2001 | WO2001097792A2 Neuraminidase inhibitors in the treatment of equine influenza virus infection |
| 12/27/2001 | WO2001097791A2 Use of c4-c10 acids for preventing gram-negative bacterial infections |
| 12/27/2001 | WO2001097790A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 12/27/2001 | WO2001097789A2 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors |
| 12/27/2001 | WO2001097788A2 Method of administering bisphosphonates |
| 12/27/2001 | WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | WO2001097786A2 Benzothiazole derivatives |
| 12/27/2001 | WO2001097785A2 Basic copolymers for the treatment of prion-related-disease |
| 12/27/2001 | WO2001097782A1 Stable gabapentin having ph within a controlled range |
| 12/27/2001 | WO2001097781A1 Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake |
| 12/27/2001 | WO2001097780A2 Pharmaceutical compositions comprising an opioid analgesic |
| 12/27/2001 | WO2001097779A2 Improved injectable dispersions of propofol |
| 12/27/2001 | WO2001097778A2 Amphotericin b structured emulsion |
| 12/27/2001 | WO2001097775A2 Controlled release anti-inflammatory formulation |
| 12/27/2001 | WO2001097771A2 Preparations that contain an extract of the plant pistia stratiotes |
| 12/27/2001 | WO2001097770A1 Method for protecting human skin |
| 12/27/2001 | WO2001097753A2 Novel methods using pyridine derivatives |
| 12/27/2001 | WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 12/27/2001 | WO2001097750A2 Method for producing an antiviral agent |
| 12/27/2001 | WO2001097749A2 The use of synthetic, non-hormonal 21-aminosteroids and thereof |
| 12/27/2001 | WO2001097627A1 Throat care agents |
| 12/27/2001 | WO2001097618A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 12/27/2001 | WO2001097612A1 Stable gabapentin containing more than 2o ppm of chlorine ion |
| 12/27/2001 | WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 12/27/2001 | WO2001077109A3 Sodium salt of an azo derivative of 5-aminosalicylic acid |
| 12/27/2001 | WO2001070216A3 Diphenyl ketoaldehyde derivatives with anti-hiv activity |
| 12/27/2001 | WO2001066116A8 Method for modulating tumor growth and metastasis of tumor cells |